Moderna cuts 2025 sales forecast by $1B

I show You how To Make Huge Profits In A Short Time With Cryptos!

MODERNA cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for Covid-19 vaccines, sending its shares down more than 24 percent in early trading.

Demand for its Covid vaccine has been waning since the pandemic, while adoption of its RSV shot its second approved product has been slower than expected, forcing Moderna to cut costs.

Be the first to comment

Leave a Reply

Your email address will not be published.


*